Sistema de Salut de Catalunya
Institut Català de la Salut
[Mollan SP] Neuro-ophthalmology, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, Birmingham, UK. Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. [Fraser CL] Save Sight Institute, University of Sydney, Sydney, NSW, Australia. [Digre KB] Neuro-ophthalmology Division, John A. Moran Eye Center, University of Utah, Salt Lake City, USA. [Diener HC] Institut für Medizinische Informatik, Biometrie undEpidemiologie (IMIBE), Medizinische Fakultät der Universität Duisburg-Essen, Essen, Germany. [Lipton RB] The Saul R. Korey Department of Neurology, and the Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, New York, USA. [Juhler M] Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. [Pozo-Rosich P] Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
Vall d'Hebron Barcelona Hospital Campus
2023-09-19T08:52:17Z
2023-09-19T08:52:17Z
2023-08
Idiopathic intracranial hypertension; Pseudotumor cerebri; Randomised control trial
Hipertensión intracraneal idiopática; Pseudotumor cerebral; Ensayo de control aleatorio
Hipertensió intracranial idiopàtica; Pseudotumor cerebral; Assaig de control aleatori
The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.
KBD is supported in part by an Unrestricted Grant from Research to Prevent Blindness, New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah.
Article
Versió publicada
Anglès
Assaigs clínics - Disseny; Hipertensió intracranial - Tractament; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics::Clinical Studies as Topic::Clinical Trials as Topic::Controlled Clinical Trials as Topic; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Intracranial Hypertension::Pseudotumor Cerebri; Other subheadings::Other subheadings::/therapy; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::características de los estudios epidemiológicos::estudios clínicos como asunto::ensayos clínicos como asunto::ensayos clínicos controlados como asunto; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::hipertensión intracraneal::seudotumor cerebral; Otros calificadores::Otros calificadores::/terapia
SAGE Publications
Cephalalgia;43(8)
https://doi.org/10.1177/03331024231197118
Attribution-NonCommercial 4.0 International
http://creativecommons.org/licenses/by-nc/4.0/
Articles científics - HVH [3439]
Articles científics - VHIR [1665]
